QVCAQ

SEC source: 0001225208-22-004631 · doc4.xml · nonDerivative · entry 1

ROSENTHALER ALBERT E · CIK 0001195195 · Chief Corp. Dev. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,438

F1 · shares: Represents shares of Series A Common Stock to be issued as a result of the certification on March 10, 2022 of the satisfaction of performance criteria established for the performance-based restricted stock units granted to the reporting person on March 10, 2021.

SEC source: 0001225208-22-004633 · doc4.xml · nonDerivative · entry 1

Wilm Renee L · CIK 0001789667 · Chief Legal/Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,763

F1 · shares: Represents shares of Series A Common Stock to be issued as a result of the certification on March 10, 2022 of the satisfaction of performance criteria established for the performance-based restricted stock units granted to the reporting person on March 10, 2021.

SEC source: 0001225208-22-004632 · doc4.xml · nonDerivative · entry 1

Wendling Brian J · CIK 0001663090 · CAO/PFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,428

F1 · shares: Represents shares of Series A Common Stock to be issued as a result of the certification on March 10, 2022 of the satisfaction of performance criteria established for the performance-based restricted stock units granted to the reporting person on March 10, 2021.

SEC source: 0001225208-22-004630 · doc4.xml · nonDerivative · entry 1

Rawlinson David · CIK 0001698247 · Director · President/CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,088

F1 · shares: Represents shares of Series A Common Stock to be issued as a result of the certification on March 10, 2022 of the satisfaction of performance criteria established for the performance-based restricted stock units granted to the reporting person on August 18, 2021.

SEC source: 0001225208-21-015122 · doc4.xml · derivative · entry 1

DIAS FIONA P · CIK 0001209881 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,954

Underlying: Series A Common Stock · 69 shares

Expires not disclosed

F1 · derivative.exercise_price: On November 4, 2021, the Issuer announced that its board of directors declared a quarterly cash dividend in the amount of $2.00 per share on each outstanding share of its 8.0% Series A Cumulative Redeemable Preferred Stock ("Preferred Stock") payable on December 15, 2021 to all holders of record as of the close of business on November 30, 2021 (the "Dividend"). The dividend equivalent rights accrued on restricted stock units with respect to the Issuer's Preferred Stock ("Original RSUs") held by the reporting person as a result of the Dividend and are subject to the same terms and conditions (including vesting and expiration) as the Original RSUs to which they relate. Each dividend equivalent right entitles the reporting person to received one share of the Issuer's Series A common stock. The grant of dividend equivalent rights was approved by the Issuer's board of directors pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended.

F2 · derivative.exercise_date: Each dividend equivalent right vests upon the reporting person's termination of service to the Issuer's board of directors.

F3 · derivative.expiration_date: Each dividend equivalent right expires upon the reporting person's termination of service to the Issuer's board of directors.

SEC source: 0001225208-21-014934 · doc4.xml · derivative · entry 2

Wong Andrea L · CIK 0001490754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Series A Common Stock · 5,841 shares

Expires 2021-12-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

SEC source: 0001225208-21-014934 · doc4.xml · nonDerivative · entry 1

Wong Andrea L · CIK 0001490754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,415

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit converted into one share of Series A Common Stock.

SEC source: 0001225208-21-014932 · doc4.xml · derivative · entry 2

Gilchrist Malcolm Ian Grant · CIK 0001469449 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Series A Common Stock · 11,683 shares

Expires 2021-12-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

SEC source: 0001225208-21-014932 · doc4.xml · nonDerivative · entry 1

Gilchrist Malcolm Ian Grant · CIK 0001469449 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,683

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit converted into one share of Series A Common Stock.

SEC source: 0001225208-21-014933 · doc4.xml · derivative · entry 2

MALONE EVAN DANIEL · CIK 0001442645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Series A Common Stock · 11,683 shares

Expires 2021-12-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

SEC source: 0001225208-21-014933 · doc4.xml · nonDerivative · entry 1

MALONE EVAN DANIEL · CIK 0001442645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,381

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit converted into one share of Series A Common Stock.

SEC source: 0001225208-21-014930 · doc4.xml · derivative · entry 3

GEORGE MICHAEL A · CIK 0001280367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Series A Common Stock · 423,403 shares

Expires 2021-12-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

SEC source: 0001225208-21-014930 · doc4.xml · nonDerivative · entry 2

GEORGE MICHAEL A · CIK 0001280367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,052,236

SEC source: 0001225208-21-014930 · doc4.xml · nonDerivative · entry 1

GEORGE MICHAEL A · CIK 0001280367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,236,332

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit converted into one share of Series A Common Stock.

SEC source: 0001225208-21-014931 · doc4.xml · derivative · entry 2

DIAS FIONA P · CIK 0001209881 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Series A Common Stock · 11,683 shares

Expires 2021-12-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

SEC source: 0001225208-21-014931 · doc4.xml · nonDerivative · entry 1

DIAS FIONA P · CIK 0001209881 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,128

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit converted into one share of Series A Common Stock.

SEC source: 0001225208-21-014926 · doc4.xml · derivative · entry 3

Rawlinson David · CIK 0001698247 · President/CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 442,713

Underlying: Series A Common Stock · 66,152 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

F3 · derivative.exercise_date: This restricted stock unit award vested 13% on December 10, 2021, and will vest 29% on each of December 10, 2022, December 10, 2023, and December 10, 2024.

F3 · derivative.expiration_date: This restricted stock unit award vested 13% on December 10, 2021, and will vest 29% on each of December 10, 2022, December 10, 2023, and December 10, 2024.

SEC source: 0001225208-21-014926 · doc4.xml · nonDerivative · entry 2

Rawlinson David · CIK 0001698247 · President/CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,389

SEC source: 0001225208-21-014926 · doc4.xml · nonDerivative · entry 1

Rawlinson David · CIK 0001698247 · President/CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,152

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit converted into one share of Series A Common Stock.

SEC source: 0001225208-21-014642 · doc4.xml · derivative · entry 1

ROMRELL LARRY E · CIK 0001120556 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,188

Underlying: Series A Common Stock · 14,188 shares

Expires 2022-12-06

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

SEC source: 0001225208-21-014644 · doc4.xml · derivative · entry 1

Wong Andrea L · CIK 0001490754 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,188

Underlying: Series A Common Stock · 14,188 shares

Expires 2022-12-06

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

SEC source: 0001225208-21-014645 · doc4.xml · derivative · entry 1

Gilchrist Malcolm Ian Grant · CIK 0001469449 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,188

Underlying: Series A Common Stock · 14,188 shares

Expires 2022-12-06

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

SEC source: 0001225208-21-014648 · doc4.xml · derivative · entry 1

MALONE EVAN DANIEL · CIK 0001442645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,188

Underlying: Series A Common Stock · 14,188 shares

Expires 2022-12-06

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

SEC source: 0001225208-21-014643 · doc4.xml · derivative · entry 1

VADON MARK C · CIK 0001287613 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,188

Underlying: Series A Common Stock · 14,188 shares

Expires 2022-12-06

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

SEC source: 0001225208-21-014647 · doc4.xml · derivative · entry 1

DIAS FIONA P · CIK 0001209881 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,188

Underlying: Series A Common Stock · 14,188 shares

Expires 2022-12-06

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

SEC source: 0001225208-21-014646 · doc4.xml · derivative · entry 1

BARTON RICHARD N · CIK 0001184230 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,188

Underlying: Series A Common Stock · 14,188 shares

Expires 2022-12-06

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

SEC source: 0001225208-21-014148 · doc4.xml · derivative · entry 1

DIAS FIONA P · CIK 0001209881 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,885

Underlying: Series A Common Stock · 1,293 shares

Expires not disclosed

F1 · derivative.exercise_price: On November 4, 2021, the Issuer announced that its board of directors declared a special cash dividend in the amount of $1.25 per common share payable on November 22, 2021, to all holders of record of the Issuer's common stock at the close of business on November 15, 2021 (the "Dividend"). The dividend equivalent rights accrued on restricted stock units with respect to the Issuer's common stock ("Original RSUs") held by the reporting person as a result of the Dividend and are subject to the same terms and conditions (including voting and expiration) as the Original RSUs to which they relate. Each dividend equivalent right entitles the reporting person to receive one share of the Issuer's Series A common stock. The grant of the dividend equivalent rights was approved by the Issuer's board of directors pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended.

F2 · derivative.exercise_date: Each dividend equivalent right vests upon the reporting person's termination of service to the Issuer's board of directors.

F3 · derivative.expiration_date: Each dividend equivalent right expires upon the reporting person's termination of service to the Issuer's board of directors.

SEC source: 0001225208-21-013532 · doc4.xml · nonDerivative · entry 1

GEORGE MICHAEL A · CIK 0001280367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,812,929

F1 · shares: Open market sale pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $10.380 to $10.725, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001225208-21-013024 · doc4.xml · nonDerivative · entry 1

GEORGE MICHAEL A · CIK 0001280367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,962,929

F1 · shares: Open market sale pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $10.29 to $10.60, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001225208-21-012462 · doc4.xml · derivative · entry 1

DIAS FIONA P · CIK 0001209881 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,592

Underlying: Series A Common Stock · 51 shares

Expires not disclosed

F1 · derivative.exercise_price: On August 17, 2021, the Issuer announced that an authorized committee of its board of directors declared a quarterly cash dividend in the amount of $2.00 per share on each outstanding share of its 8.0% Series A Cumulative Redeemable Preferred Stock ("Preferred Stock") payable on September 15, 2021 to all holders of record as of the close of business on August 31, 2021 (the "Dividend"). The dividend equivalent rights accrued on restricted stock units with respect to the Issuer's Preferred Stock ("Original RSUs") held by the reporting person as a result of the Dividend and are subject to the same terms and conditions (including vesting and expiration) as the Original RSUs to which they relate. Each dividend equivalent right entitles the reporting person to receive one share of the Issuer's Series A common stock. The grant of dividend equivalent rights was approved by the Issuer's board of directors pursuant to Rule 16b-3.

F2 · derivative.exercise_date: Each dividend equivalent right vests upon the reporting person's termination of service of Issuer's board of directors.

F3 · derivative.expiration_date: Each dividend equivalent right expires upon the reporting person's termination of service to the Issuer's board of directors.

SEC source: 0001225208-21-012256 · doc4.xml · nonDerivative · entry 1

GEORGE MICHAEL A · CIK 0001280367 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,112,929

F1 · shares: Open market sale pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $10.395 to $10.545, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001225208-21-011600 · doc4.xml · derivative · entry 2

Rawlinson David · CIK 0001698247 · President/CEO-Elect

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,185,053

Underlying: Series A Common Stock · 1,185,053 shares

Expires 2028-08-18

F4 · shares: This stock option is granted pursuant to the Agreement. Pursuant to the Agreement, the reporting person was entitled to receive options to acquire the Issuer's Series A common stock with a grant date value equal to $6,662,500 and with an exercise price equal to the Fair Market Value (as defined in the Qurate Retail, Inc. 2020 Omnibus Incentive Plan, as amended from time to time) on the date of grant, subject to the other terms and conditions set forth in the Agreement.

F5 · derivative.exercise_date: The options will vest 50% on December 31, 2023 and 50% on December 31, 2024.

SEC source: 0001225208-21-011600 · doc4.xml · derivative · entry 1

Rawlinson David · CIK 0001698247 · President/CEO-Elect

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 508,865

Underlying: Series A Common Stock · 508,865 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series A common stock.

F2 · shares: This grant of restricted stock units is made pursuant to the employment agreement, effective as of July 12, 2021, between the reporting person and the Issuer (the "Agreement"). Pursuant to the Agreement, the reporting person was entitled to an award of restricted stock units with respect to the Issuer's Series A common stock with a grant date value equal to $5,979,167, subject to the terms and conditions set forth in the Agreement.

F3 · derivative.exercise_date: The restricted stock units will vest 13% on December 10, 2021, and 29% on each of December 10, 2022, December 10, 2023 and December 10, 2024.

F3 · derivative.expiration_date: The restricted stock units will vest 13% on December 10, 2021, and 29% on each of December 10, 2022, December 10, 2023 and December 10, 2024.

SEC source: 0001225208-21-011523 · doc4.xml · nonDerivative · entry 1

Wilm Renee L · CIK 0001789667 · Chief Legal/Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,980

F1 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $11.0001 to $11.0201, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001225208-21-011472 · doc4.xml · nonDerivative · entry 1

GEORGE MICHAEL A · CIK 0001280367 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,262,929

F1 · shares: Open market sale pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $10.99 to $11.35, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001225208-21-010512 · doc4.xml · nonDerivative · entry 1

GEORGE MICHAEL A · CIK 0001280367 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,412,929

F1 · shares: Open market sale pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $12.37 to $12.87, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001225208-21-009470 · doc4.xml · derivative · entry 1

DIAS FIONA P · CIK 0001209881 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,541

Underlying: Series A Common Stock · 39 shares

Expires not disclosed

F1 · derivative.exercise_price: On May 20, 2021, the Issuer announced that an authorized committee of its board of directors declared a quarterly cash dividend in the amount of $2.00 per share on each outstanding share of its 8.0% Series A Cumulative Redeemable Preferred Stock ("Preferred Stock") payable on June 15, 2021 to all holders of record as of the close of business on June 1, 2021 (the "Dividend"). The dividend equivalent rights accrued on restricted stock units with respect to the Issuer's Preferred Stock ("Original RSUs") held by the reporting person as a result of the Dividend and are subject to the same terms and conditions (including vesting and expiration) as the Original RSUs to which they relate. Each dividend equivalent right entitles the reporting person to receive one share of the Issuer's Series A common stock. The grant of dividend equivalent rights was approved by the Issuer's board of directors pursuant to Rule 16b-3.

F2 · derivative.exercise_date: Each dividend equivalent right vests upon the reporting person's termination of service to the Issuer's board of directors.

F3 · derivative.expiration_date: Each dividend equivalent right expires upon the reporting person's termination of service to the Issuer's board of directors.

SEC source: 0001225208-21-009423 · doc4.xml · nonDerivative · entry 1

MALONE JOHN C · CIK 0000937797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,979,089

F1 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $13.820 to $14.025, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001225208-21-009423 · doc4.xml · nonDerivative · entry 3

MALONE JOHN C · CIK 0000937797 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Leslie A. Malone 1995 Revocable Trust

Disclosed balance after: 937,593

F4 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $13.480 to $13.670, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · ownership.nature: The reporting person disclaims beneficial ownership of these shares held by the Leslie A. Malone 1995 Revocable Trust.

SEC source: 0001225208-21-009423 · doc4.xml · nonDerivative · entry 2

MALONE JOHN C · CIK 0000937797 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Leslie A. Malone 1995 Revocable Trust

Disclosed balance after: 1,024,735

F2 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $13.410 to $13.770, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · ownership.nature: The reporting person disclaims beneficial ownership of these shares held by the Leslie A. Malone 1995 Revocable Trust.

SEC source: 0001225208-21-009238 · doc4.xml · nonDerivative · entry 4

MALONE JOHN C · CIK 0000937797 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Leslie A. Malone 1995 Revocable Trust

Disclosed balance after: 1,232,027

F4 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $13.475 to $13.595, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

F5 · ownership.nature: The reporting person disclaims beneficial ownership of these shares held by the Leslie A. Malone 1995 Revocable Trust.

SEC source: 0001225208-21-009238 · doc4.xml · nonDerivative · entry 3

MALONE JOHN C · CIK 0000937797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,000,491

F3 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $13.430 to $13.660, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001225208-21-009238 · doc4.xml · nonDerivative · entry 2

MALONE JOHN C · CIK 0000937797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,175,752

F2 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $13.550 to $13.850, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001225208-21-009238 · doc4.xml · nonDerivative · entry 1

MALONE JOHN C · CIK 0000937797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,444,360

F1 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $13.250 to $13.870, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001225208-21-009146 · doc4.xml · nonDerivative · entry 1

GEORGE MICHAEL A · CIK 0001280367 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,562,929

F1 · shares: Open market sale pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: The price is a weighted average price. These shares were sold in multiple transactions ranging from $13.10 to $13.34, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001225208-21-009056 · doc4.xml · derivative · entry 6

MAFFEI GREGORY B · CIK 0001099636 · Director · Chairman of the Board · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Series B Common Stock · 1,137,228 shares

Expires 2021-12-24

F7 · price: On June 3, 2021, pursuant to the Letter Agreement (as defined in the Remarks section), the reporting person waived his rights to assert that certain specified events described therein would constitute a "Change in Control" or "Good Reason" (as defined in his Employment Agreement (as defined in the Remarks section)) with respect to the Issuer and agreed not to terminate his employment with the Issuer in connection with such events, which would have resulted in the severance-related obligations of the Issuer described in the Remarks section, and he agreed to the cancellation of certain stock options, as reported in Table II above. In consideration of the foregoing, the reporting person received the restricted stock grant of Series B Common Stock reported in Table I above and the Issuer agreed that its portion of the reporting person's annual equity awards to be granted for 2022, 2023 and 2024 will be granted with respect to Series B Common Stock.

F6 · derivative.exercise_date: The derivative security was fully vested.

SEC source: 0001225208-21-009056 · doc4.xml · derivative · entry 5

MAFFEI GREGORY B · CIK 0001099636 · Director · Chairman of the Board · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Series B Common Stock · 197,783 shares

Expires 2022-03-31

F7 · price: On June 3, 2021, pursuant to the Letter Agreement (as defined in the Remarks section), the reporting person waived his rights to assert that certain specified events described therein would constitute a "Change in Control" or "Good Reason" (as defined in his Employment Agreement (as defined in the Remarks section)) with respect to the Issuer and agreed not to terminate his employment with the Issuer in connection with such events, which would have resulted in the severance-related obligations of the Issuer described in the Remarks section, and he agreed to the cancellation of certain stock options, as reported in Table II above. In consideration of the foregoing, the reporting person received the restricted stock grant of Series B Common Stock reported in Table I above and the Issuer agreed that its portion of the reporting person's annual equity awards to be granted for 2022, 2023 and 2024 will be granted with respect to Series B Common Stock.

F6 · derivative.exercise_date: The derivative security was fully vested.

SEC source: 0001225208-21-009056 · doc4.xml · nonDerivative · entry 3

MAFFEI GREGORY B · CIK 0001099636 · Director · Chairman of the Board · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,155,556

F2 · security: Each share of Series B Common Stock is convertible, at the holder's election, into one share of Series A Common Stock, at any time for no consideration other than the surrender of the share of Series B Common Stock for each share of Series A Common Stock.

F3 · shares: Represents a restricted stock award that is scheduled to vest, subject to the reporting person's continued employment with the Issuer, in two equal tranches on each of December 10, 2024 and the fifth anniversary of the grant date, subject to earlier vesting under certain circumstances. See also Footnote 4.

F4 · price: On June 3, 2021, pursuant to the Letter Agreement (as defined in the Remarks section), the reporting person waived his rights to assert that certain specified events described therein would constitute a "Change in Control" or "Good Reason" (as defined in his Employment Agreement (as defined in the Remarks section)) with respect to the Issuer and agreed not to terminate his employment with the Issuer in connection with such events, which would have resulted in the severance-related obligations of the Issuer described in the Remarks section, and he agreed to the cancellation of certain stock options, as reported in Table II above. In consideration of the foregoing, the reporting person received the restricted stock grant of Series B Common Stock reported in Table I above and the Issuer agreed that its portion of the reporting person's annual equity awards to be granted for 2022, 2023 and 2024 pursuant to the Employment Agreement will be granted with respect to Series B Common Stock.

SEC source: 0001225208-21-009056 · doc4.xml · nonDerivative · entry 2

MAFFEI GREGORY B · CIK 0001099636 · Director · Chairman of the Board · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,054,235

F2 · security: Each share of Series B Common Stock is convertible, at the holder's election, into one share of Series A Common Stock, at any time for no consideration other than the surrender of the share of Series B Common Stock for each share of Series A Common Stock.

F1 · shares: On June 3, 2021, the Issuer and the reporting person entered into a Stock Exchange Agreement (the "Exchange Agreement") whereby the reporting person acquired 5,378,308 shares of Series B Common Stock from the Issuer in exchange for an equivalent number of shares of Series A Common Stock. This exchange was approved by a committee of the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

F1 · price: On June 3, 2021, the Issuer and the reporting person entered into a Stock Exchange Agreement (the "Exchange Agreement") whereby the reporting person acquired 5,378,308 shares of Series B Common Stock from the Issuer in exchange for an equivalent number of shares of Series A Common Stock. This exchange was approved by a committee of the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

SEC source: 0001225208-21-009056 · doc4.xml · nonDerivative · entry 1

MAFFEI GREGORY B · CIK 0001099636 · Director · Chairman of the Board · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: On June 3, 2021, the Issuer and the reporting person entered into a Stock Exchange Agreement (the "Exchange Agreement") whereby the reporting person acquired 5,378,308 shares of Series B Common Stock from the Issuer in exchange for an equivalent number of shares of Series A Common Stock. This exchange was approved by a committee of the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

F1 · price: On June 3, 2021, the Issuer and the reporting person entered into a Stock Exchange Agreement (the "Exchange Agreement") whereby the reporting person acquired 5,378,308 shares of Series B Common Stock from the Issuer in exchange for an equivalent number of shares of Series A Common Stock. This exchange was approved by a committee of the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.